ArticleJournal of cancer science & therapy2014

Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway.

Mi-Heon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.